Table 1.
Baseline Patient Characteristics: Comparison Between Patients Who Developed Hepatic Steatosis and Those Who did Not After Pancreatic IPMN Resections.
| With steatosis | Without steatosis | P-value | |
|---|---|---|---|
| Female | 68% | 32% | 0.76 |
| Male | 62% | 38% | |
| Age (years) | 63 ± 11.1 | 65 ± 9.3 | 0.89 |
| IPMN size (cm) | 2.7 ± 1.3 | 2.3 ± 1.4 | 0.68 |
| PD | 69% | 31% | 0.55 |
| DP | 60% | 40% | |
| Weight0 (kg) | 71.9 ± 14.5 | 72.3 ± 16.5 | 0.55 |
| BMI0 (kg/m2) | 24.7 ± 3.3 | 25.2 ± 4.3 | 0.14 |
| FBG0 (mg/dL) | 94.9 ± 10.1 | 96.9 ± 9.9 | 0.58 |
| ALP0 (IU/L) | 79.9 ± 21.0 | 76.8 ± 24.6 | 0.20 |
| AST0 (U/L) | 28.8 ± 12.2 | 26.1 ± 7.8 | 0.05 |
| ALT0 (IU/L) | 26.3 ± 13.9 | 26.9 ± 13.4 | 0.60 |
| T. Chol0 (mg/dL) | 189.4 ± 34.5 | 188.4 ± 31.2 | 0.41 |
| T. Trig0 (mg/dL) | 140.3 ± 42.1 | 120.9 ± 43.3 | 0.61 |
| LFSF0 | 1.5% ± 1.0% | 1.7% ± 1.3% | 0.16 |
| LFSF1 | 21.9% ± 14.6% | 2.5% ± 1.2% | <0.01a |
DP, distal pancreatectomy; LFSF, liver fat signal fraction; PD, pancreaticoduodenectomy; Subscript 0: before surgery; Subscript 1: after surgery.
a
Statistical significance.